Recommendation to include colorectal cancer screening in public health policy

Journal of Medical Screening

Volumn 6, Issue 2, 1999, Pages 80-81

  Bertario, Lucio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; EUROPE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; UTERINE CERVIX CANCER;

EID: 0033031793     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.6.2.80     Document Type: Article

References (22)

1. Australian Cancer Society. Guidelines far early detection, screening and surveillance for colorectal cancer. 2nd ed. 1994.
2. Bertario L, Sala P, Russo A, et al. Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study. Eur J Cancer (in press).
3. Byers T, Levin B, Rothenberger D, et al for the American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. CA Cancer J Clin 1997;47:154-60.
4. Church TR, Ederer F, Mandel JS. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J Natl Cancer Inst 1997;89:1440-8.
5. Faivre J, Tazi MA, Mrini TEL, et al. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer (in press).
6. Fric P, Zavoral M, Dvorakova H, et al. An adapted program of colorectal cancer screening - 7 years experience and cost-benefit analysis. Hepatogastroenterology 1994;41:413-16.
7. Gnauck R. Screening for colon cancer in Germany. Tumori 1995;81(suppl):30-7.
8. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
9. Kewenter J, Brevinge H, Engaras B, et al. Results of screening, rescreening and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Scand J Gastroenterol 1994;29:468-73.
10. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
11. Lieberman D. Mass screening: North American perspective. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: Saunders, 1996:289 -300.
12. Mandel JS, Bond JH, Church TR, et al for the Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
13. Saito H, Soma Y, Koeda J, et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunchemical hemagglutination test. A case-control study. Int J Cancer 1995;61:465-9.
14. Selby JV, Friedman GD, Quesenberry CP, et al. Effect of fecal occult blood testing on mortality from colorectal cancer - a case-control study. Ann Intern Med 1993;118:1-6.
15. Wada T, Saito H, Soma Y, et al. Survival benefit for patients with colorectal cancer detected by population-based screening program using an immunological fecal occult blood test. Int J Oncol 1996;9:685-91.
16. Wagner JL, Tunis S, Brown M, et al. Cost effectiveness of colorectal cancer screening. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: Saunders, 1996:321-56.
17. Wahrendorf J, Robra BP, Wiebelt H, et al. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 1993;2:221-7.
18. Whynes DK. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial. Forum DKG 1998;13:109-11.
19. Winawer SJ and the WHO-Collaborating Center for the Prevention of Colorectal Cancer. Prevention of colorectal cancer: guidelines based on new data. Bull World Health Organ 1995;73:7-10.
20. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
21. Young GP, Macrae FA, St John DJB. Clinical methods for early detection: basis, use, and evaluation. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: Saunders, 1996:241-70.
22. Zappa M, Castiglione G, Grazzini G, et al. Effects of faecal occult blood testing on colorectal cancer mortality. Results of a population-based case control study the district of Florence. Int J Cancer 1997;73:208-10.